## IVZ: Invesco Ltd. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.46 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: declining volume (45% of avg), momentum weakening (-3.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($25.61)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Invesco Rochester Limited Term New York Municipal Fund Q3 2025 Commentary (Mutual Fund:LTNYX)**
- Source: Seeking Alpha | 20251226T111714 | Bullish | Relevance: 100%
- In Q3 2025, the Invesco Rochester Limited Term New York Municipal Fund Class A shares (LTNYX) outperformed its benchmark, the S&P Municipal New York Investment Grade 4-7 Years Bond Index. This was supported by the Federal Reserve's first rate cut of the year and the fund's overweighting in bonds with 10-15 year durations. The fund sees continued opportunities in the municipal bond market, focusing on revenue bonds and utilizing bottom-up research to navigate credit conditions.

**2. Invesco Quality Income Fund Q3 2025 Commentary (Mutual Fund:VUSIX)**
- Source: Seeking Alpha | 20251225T125220 | Somewhat-Bullish | Relevance: 100%
- The Invesco Quality Income Fund's commentary for Q3 2025 highlights a flattening yield curve, reflecting investor caution and uncertainty. While valuations for Agency mortgage-backed securities have become less compelling, the fund's Class A shares achieved positive absolute returns and outperformed its benchmark. The report also notes expected Fed rate cuts for the remainder of 2025.

**3. The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley**
- Source: The Globe and Mail | 20251224T160820 | Bullish | Relevance: 98%
- The Zacks Analyst Blog identifies five high-yield S&P 500 stocks—Invesco Ltd. (IVZ), Johnson & Johnson (JNJ), NiSource (NI), Bunge Global SA (BG), and Morgan Stanley (MS)—as strong buy candidates for 2026. These companies are selected based on their solid fundamentals, resilient business models, sustainable payout histories, and attractive dividend yields of 2% or more, coupled with a five-year dividend growth rate exceeding 5%. The article also discusses the U.S. economic outlook for 2026, foreseeing measured growth, easing inflation, and the continued importance of dividend investing for reliable returns.

**4. The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley**
- Source: The Globe and Mail | 20251224T171018 | Bullish | Relevance: 98%
- This Zacks Analyst Blog highlights five high-yield S&P 500 stocks—Invesco, Johnson & Johnson, NiSource, Bunge Global, and Morgan Stanley—recommended for reliable returns in 2026. The article discusses general economic trends for 2025 and 2026, emphasizing dividend investing as a robust strategy. These selected stocks boast strong fundamentals, solid dividend yields, and impressive historical dividend growth.

**5. Vontobel Holding Ltd. Sells 239,279 Shares of Invesco Ltd. $IVZ**
- Source: MarketBeat | 20251226T133351 | Neutral | Relevance: 96%
- Vontobel Holding Ltd. significantly reduced its stake in Invesco Ltd. (NYSE:IVZ) by selling 239,279 shares, decreasing its position by 56.4% to 184,742 shares valued at approximately $4.24 million. Other institutional investors, such as KLP Kapitalforvaltning AS and First Trust Advisors LP, either boosted or acquired new stakes in the asset manager. Invesco recently beat quarterly expectations with an EPS of $0.61 against an expected $0.44 and reported revenue of $1.19 billion, while also announcing a quarterly dividend of $0.21 per share.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $28 | $27 | +4% |
| 2025-12-17 | Deutsche Bank | $31 | $26 | +19% |
| 2025-12-12 | Barclays | $28 | $25 | +12% |
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Deutsche Bank | up | Buy |
| 2025-12-12 | Barclays | main | Equal-Weight |
| 2025-12-10 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($2.51M) |
| Sells | 5 ($4.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Insider selling cluster: $4.6M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.46 indicates undervaluation relative to growth. Forward P/E 10.7x attractive for 27% earnings growth. Quality metrics strong (margin 17%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.48 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.46 |
| Forward P/E | 10.7 |
| Current P/E | 13.6 |
| YoY Growth | 27.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.7% to 2.2% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.8pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 45% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.23% (CS: 79) | Neutral |
| RSI_14 | 63.4 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.101x | Above |
| vs SMA200 | 1.381x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $26.95
- **Stop Loss:** $25.61 (5.0% risk)
- **Target:** $29.63 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 985
- **Position Value:** $26,545.75
- **Portfolio %:** 26.55%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*